We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A senior FDA official who oversees women’s health issues has resigned in protest of the agency’s recent decision to postpone ruling on the OTC status of Barr Pharmaceuticals’ Plan B emergency contraceptive.